New

Telemedicine Shows Promise to Improve Geriatric Psychiatric Care

Telepsychiatry services for elderly patients may increase access to geriatric specialists, reduce travel time for both providers and patients, and reduce healthcare costs.

New

THINC-Integrated Tool Measures Cognition in Depression Disorder Screenings

The use of a recently developed computerized screening tool, THINC-it, provides both objective and subjective measures of cognitive function in adults with major depressive disorder.

New

Painting Ketamine in a Bad Light

Studies of the use of ketamine for depression revealed that the agent induces a rapid reduction in depressive symptoms and suicidal ideation in most patients.

New

Long-Term Lithium Use: More Evidence Needed to Associate With Cancer Risk

The European Medicine Agency has reported that there may be an association between long-term lithium use and reports of both renal tumors and thyroid cancer.

New

Sleep Deprivation Not Schizotypy Validated as Model System of Psychosis

Researchers aimed to validate sleep deprivation and schizotypy as putative models of psychosis by replicating their effects on cognitive performance.

New

Wikipedia in Medical Education: An Educator’s Guide to Crowdsourcing

With the proliferation of online medical information, educators and students alike struggle to discern the legitimacy of “e-health” sources.

New

Follow-Up Care After First Emergency Department Visit for Youth With Psychotic Disorders

Adolescents and young adults who visit emergency departments for psychotic disorder for the first time often do not receive timely follow-up care.

New

Overcoming the Barriers to Including Pregnant Women in Clinical Trials

Pregnant women are considered a “vulnerable” population in the eyes of clinical researchers.

New

Evzio Authorized Generic Soon to Be Available

An authorized generic version of Evzio is expected to be available next year at a price of $178 per carton.

New

Sleep Problems Influence Peer Victimization Outcomes in Older Adolescent Girls

Study demonstrated that the effects of peer victimization on depressive symptoms in adolescent girls were in part due to sleep problems.

New

AMA Survey Collects Advice for Physicians Approaching Retirement

The transition from the workforce into retirement is always challenging, but for physicians accustomed to working long or odd hours, it can be especially difficult.

New

Prescription Digital Therapeutic Approved for Opioid Use Disorder

Sandoz and Pear Therapeutics announced that the FDA has granted clearance for reSET-O, the first prescription digital therapeutic for patients with opioid use disorder.

New

Etiology of Schizophrenia: Strong Association With Certain Rare Copy Number Variants

Genetic risk from rare copy number variants and common single-nucleotide polymorphisms may contribute to liability to schizophrenia.

New

Revised Children’s Anxiety and Depression Scales Reliable Measurement Tool for Adults

RCADS is often used to measure anxiety and depression and researchers assessed its structural validity for adults, given the life span nature of anxiety.

New

Symptom Improvement Seen With Interpersonal Psychotherapy, Sertraline in Postpartum Women

Investigators examined the efficacy of sertraline and interpersonal psychotherapy vs pill placebo over 12 weeks in woman with postpartum depression.

New

FDA to Review Lumateperone for Treatment of Schizophrenia

Lumateperone and follow-on compounds are also being evaluated for bipolar depression, behavioral disturbance associated with dementia, sleep disturbances associated with neuropsychiatric disorders, and other neuropsychiatric conditions including major depressive disorder and autism.

New

Polygenic Risk Scores May Predict Antipsychotic Efficacy in Schizophrenia

The use of a polygenic risk score for schizophrenia can effectively predict an antipsychotic treatment response after a first episode of psychosis.